Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation
AssigneeStrongbone AB
InventorsAnders Grubb, Franciszek Kasprzykowski, Ulf Lerner, Beata Zolnowska, Regina Kasprzykowska
Life of this patent
Estimating the term…
Abstract
Compounds of formula R1-A-NH—CH(R2)—CO—R3 are presented. The compounds can be used to treat or alleviate conditions associated with bone loss or low bone density, or to inhibit osteoclast differentiation and stimulation, bone resorption and/or loosening of a prosthetic device. The compounds can be administered as a pharmaceutical composition or in a prosthetic device.
Claims9
A method of treating a condition associated with bone loss or low bone density or for inhibiting osteoclast differentiation and stimulation or bone resorption in a mammal in need thereof, comprising administering to said mammal an effective amount of one or more compounds selected from the group consisting of A-20, A-33, A-42, A-47, A-59, and A-107:
- the one or more compound being a single stereoisomer or a mixture of different stereoisomers, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.